Allotransplantation

Allotransplant (allo- meaning "other" in Greek) is the transplantation of cells, tissues, or organs to a recipient from a genetically non-identical donor of the same species. [1]The transplant is called an allograft, allogeneic transplant, or homograft. Most human tissue and organ transplants are allografts.

Not to be confused with Allogenic succession.
Allotransplants
MeSHD014184

It is contrasted with autotransplantation (from one part of the body to another in the same person), syngeneic transplantation of isografts (grafts transplanted between two genetically identical individuals of the same species) and xenotransplantation (from other species).

Allografts can be referred to as "homostatic" if they are biologically inert when transplanted, such as bone and cartilage.[2]

An immune response against an allograft or xenograft is termed rejection. An allogenic bone marrow transplant can result in an immune attack on the recipient, called graft-versus-host disease.

Procedure

Material is obtained from a donor who is a living person, or a deceased person's body receiving mechanical support or ventilation, or a deceased person's body whose heart stopped beating. Screening for pathology and risk factors for communicable diseases such as HIV and Hepatitis B and C is then conducted.

In the US, donor tissue must be recovered and processed adhering to the Current Good Tissue Practices rule. In most cases, it is sent to tissue banks for processing and distribution. Each year, Food and Drug Administration regulated and American Association of Tissue Banks-accredited tissue banks distribute 1.5 million bone and tissue allografts.

Transplantable organs and tissues
Main article: Transplantable organs and tissues

A variety of organs and tissues can be used for allografts, including:

Laws and regulations

In the US, the Federal government Food and Drug Administration (FDA) has regulated human tissue intended for transplants since 1993. In order to ensure the quality of donor tissue and reduce contamination and disease transmission risks, three regulations addressing manufacturing activities associated with human cells, tissues, and cellular and tissue-based products (HCT/Ps) were promulgated in May 2005: The first requires companies producing and distributing HCT/Ps to register with the FDA. The second, called the “Donor Eligibility” rule, proscribes criteria for donor eligibility. The third, the “Current Good Tissue Practices” rule, oversees overall processing and distribution practices of each company.

Other transplant options
  • Autograft, tissue transplanted from one site to another on the same patient. An autograft reduces the risk of rejection but requires a second surgery site, adding pain, risk and possible longer aftercare.
  • Xenograft, a transplant from another species
  • Isograft, a transplant from a genetically identical donor, such as an identical twin.
  • Synthetic and metal implants. Unlike allografts, such grafts do not corporate into the body.

Risks

As with many operations, allotransplantation also has some side effects. A limiting factor in tissue allotransplantation for reconstructive surgery deals with the side effects of immunosuppression (metabolic disorders, malignancies, opportunistic infections) which is a predominant issue. Also, it can not be forgotten that the risk of transmitting infection is very high.[3]

gollark: Why not use localStorage? Does the server need to access the hunger too?
gollark: I am feeding my pet every 10 milliseconds.
gollark: It feels okay after i refreshed, yay.
gollark: HELPHELPHOW DO I SATIATE ITS UNENDING HUNGER
gollark: HELPMY PET IS HUNGRYHOW DO I FEED ITIT IS STILL HUNGRY AND I CLICKED FEEDAAAAAAAAAAAA

See also
  • Allograft diseases
  • Medical grafting

References
  1. Surgery For ACL Tears
  2. (W. P. Longmire, J. National Cancer Institute 14, 669: The term homostatic graft might be applied to inert tissues such as bone and cartilage when transferred from one individual to another of the same species; and the term homovital graft might be used in reference to grafts whose cells must continue to grow and reproduce for the graft to be effective after similar transplantation; H. Conway, The Bulletin of the Hong Kong Chinese Medical Association 13, 43: These grafts persist however as homostatic grafts and are completely replaced by host tissues in time.)
  3. Petit, F.; Minns, A. B.; Dubernard, J. M.; Hettiaratchy, S.; Lee, W. P. (2003). "Composite Tissue Allotransplantation and Reconstructive Surgery". Annals of Surgery. 237 (1): 19–25. doi:10.1097/00000658-200301000-00004. PMC 1513974. PMID 12496526.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.